LifeTech Scientific Announces Online Release of 2026 Interim Report and Offers Print Copies on Request

Bulletin Express
Sep 11

LifeTech Scientific Corporation released its Interim Report 2026 on 11 September 2026. Both the English and Chinese versions are available for download on the company’s website (www.lifetechmed.com) and on the Hong Kong Stock Exchange’s website (www.hkexnews.hk).

Non-registered shareholders are encouraged to access the digital version but may request printed copies at no cost. To obtain hard copies of the current or future corporate communications, shareholders should complete the enclosed request form and return it to Tricor Investor Services Limited, the company’s Hong Kong branch share registrar, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, using the prepaid mailing label, or email their request to is-ecom@vistra.com.

Shareholders who prefer to receive communications electronically must provide a functional email address to their custodial intermediaries—banks, brokers, custodians, nominees, or HKSCC Nominees Limited. Until an email address is supplied via these channels, the company will issue only printed notices of publication.

Enquiries can be directed to Tricor’s hotline at (852) 2980 1333 between 9:00 a.m. and 6:00 p.m., Monday to Friday (excluding Hong Kong public holidays).

The notification was issued under the authority of Executive Director, Chairman and Chief Executive Officer Mr. Xie Yuehui on behalf of the Board of LifeTech Scientific Corporation.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10